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Limited availability of fish oils (FO), rich in omega-3 long-chain (≥C20) polyunsaturated fatty 
acids (FA), is a major constraint for further growth of the aquaculture industry. Long-chain 
omega-3 rich oils from crops genetically modified with algal genes are promising new sources 
for the industry. This project studied the use of a newly developed omega-3 canola oil (DHA-
CA) in diets of Atlantic salmon fingerlings in freshwater. The DHA-CA oil has high 
proportions of the omega-3 FA 18:3n-3 and DHA and lower proportions of omega-6 FA than 
conventional plant oils. Levels of phytosterols, vitamin E, and minerals in the DHA-CA were 
within the natural variation of commercial canola oils. Pesticides, mycotoxins, polyaromatic 
hydrocarbons, and heavy metals were below lowest qualifiable concentration. Two feeding 
trials were conducted to evaluate effects of two dietary levels of DHA-CA compared to two 
dietary levels of FO at two water temperatures. Fish increased their weight approximately 20-
fold at 16 °C and 12-fold at 12 °C during the experimental periods, with equal growth in 
salmon fed the FO diets compared to DHA-CA diets. Salmon fed DHA-CA diets had 
approximately the same EPA+DHA content in whole body as salmon fed FO diets. Gene 
expression, lipid composition, and oxidative stress related enzyme activities showed only 
minor differences between the dietary groups and the effects were mostly a result of dietary 
oil level, rather than the oil source. The results demonstrated that DHA-CA is a safe and 
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1. Introduction   
Diets for farmed Atlantic salmon, Salmo salar, have changed considerably during the last 
decades. In Norway, while 90% of the ingredients were of marine origin in the 1990s, current 
diets only contain approximately 30% marine ingredients 
(1)
. This situation is very similar in 
Chile, Canada, and Australia, whereas salmon diets used in Scotland in 2013/14 contained 
60% plant ingredients and 40% marine ingredients on average 
(2)
. The shift from marine to 
plant ingredients, or in some cases land animal-by products, has been driven by the need of 
the feed producers to reduce dietary reliance on the finite marine-derived ingredients fish oil 
(FO) and fish meal (FM) to secure global aquaculture production 
(3)
. However, vegetable oils 
are naturally devoid of the nutritionally beneficial omega-3 (n-3) long-chain (≥C20) 
polyunsaturated fatty acids (LC-PUFA) eicosapentaenoic acid (EPA; 20:5n-3) and 
docosahexaenoic acid (DHA; 22:6n-3), and cannot be used as the sole oil source in fish diets 
with a low FM content, since EPA and DHA are essential FA in salmon diets 
(4; 5)
. The 
physiological relevance of these fatty acids (FA) is well recognized, being involved in 
maintaining the structural and functional integrity of cellular membranes, acting as precursors 
of important metabolites, such as eicosanoids, and working as signalling molecules able to 
regulate the transcription of genes involved in lipid metabolism 
(6; 7)
.  
The Norwegian, Scottish, and Australian salmon industries have reported a significant 
decrease in the absolute amounts of EPA and DHA in salmon fillets and a concomitant 
increase in FA typical of terrestrial-derived lipid sources, reflecting the changes in the feed 
formulation throughout the years 
(1; 2; 8; 9; 10)
. In addition, the high inclusion levels of vegetable 
and/or animal oils rich in n-6 FA in salmon diets result in an associated increase in the n-6/n-3 
ratio in fish organs and tissues, including fish fillets 
(11)
. This is an important issue that might 
affect not only fish and human consumer health, but also influence consumer perspectives 
towards farmed fish. Alternative sources of n-3 LC-PUFA oils are being pursued, however, 
neither oils from traditional oilseeds such as linseed, nor the genetically modified SDA 




In terrestrial genetically modified (GM) plant oils, enriched levels of DHA have been 
achieved, combined with lower n-6 PUFA levels than occurs in conventional canola oils 
(12; 13; 
14; 15)
. Today, close to 70% of the oil fraction in feeds for Atlantic salmon in Norway consists 
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diets. In addition, several Atlantic salmon feeding studies using GM plant material from 





GM camelina oil rich in EPA, although containing a high level of n-6 FA, has been tested in 
diets of post smolt Atlantic salmon. This oil did not influence the fish performance relative to 
a FO diet; however liver transcriptome analyses revealed that the response in fish was closer 
to the expected response to plant oils than to that of FO 
(17)
. Some studies have shown that 
Atlantic salmon have a more defined requirement for DHA than for EPA 
(18; 19; 20)
. When 
replacing conventional feed ingredients with new ingredients, it is important to ensure that 
they are as safe as traditional products.   
In the present study, two separate feeding trials with DHA-CA oil were performed, one in 
Australia at a water temperature of 16°C and one in Norway at a lower water temperature of 
12°C. The overall study was undertaken to determine if the new DHA-CA oil containing 
enhanced levels of n-3 LC-PUFA and a lower level of n-6 LC-PUFA than conventional 
canola oils, would influence growth, performance, health, and n-3 LC-PUFA, content in 
different organs and tissues in Atlantic salmon fingerling.  
 
2. Material and methods 
2.1.Canola oils 
The DHA-CA tested in the experiment was obtained from Event NS-B50027-4, which is a 
modified canola (Brassica napus) line developed by Nuseed Pty. Ltd. (Australia). The 
transgenic seeds were modified to produce the long-chain polyunsaturated PUFA - EPA and 
DHA; construct details are provided in Petrie et al. 
(15)
. The crop used in this trial was grown 
in Australia during 2015 and 2016. The control canola oil used in the diets was an Australian 
variety (Garnet) with an oil profile similar to that of the parent (untransformed) line from 
which NS-B50027-4 was derived; this oil is defined as Ctr-CA in this study. Oils were cold-
pressed and filtered. 
 
2.2.Analyses of elements and undesirables in the oils 
Multielement determination of the oils was done by ICP-MS (inductively coupled plasma 
mass spectrometry) 
(21)
 while analysis of selected undesirable compounds were conducted by 
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00) Chlorinated pesticides (aldrin; chlordane, cis-; chlordane, oxy-; chlordane, trans-; dieldrin; 
endrin; gamma-HCH (lindane); HCH, alpha-; HCH, beta-; HCH, delta-; heptachlor; 
heptachlor epoxide, cis-; heptachlor epoxide, trans-; hexachlorobenzene (HCB); mirex; 
nonachlor, trans-; o,p'-DDD; o,p'-DDE; o,p'-DDT; octachlorstyrene; p,p'-DDD; p,p'-DDE; 
p,p'-DDT; pentachlorobenzene; toxaphene parlar 26; toxaphene parlar 50; toxaphene parlar 
62, endosulfan (-alpha,-beta,-sulfat), toxaphene -26, -50, -60),  organophosphate pesticides 
(119 compounds), 16 PAH-compounds (benzo(a)antracene, benzo(a)pyrene, 
benzo(b)fluoranthene, benzo(c)fluorene, benzo(ghi)perylene, benzo(j)fluoranthene 
benzo(k)fluoranthene, chrysene, cyclopenta(cd)pyrene, dibenz(ah)anthracene, indeno(1,2,3-
cd)pyrene, 5-methylchrysene, dibenzo(a,e)pyrene, dibenzo(a,h)pyrene, dibenzo(a,i)pyrene 
and Dibenzo(a,l)pyrene) and five lipid-soluble mycotoxins beauvericin and enniatin (A, A1, B 
and B1) were analyzed in the oils. 
 
2.3. Experimental diets used in the 16 °C and 12 °C trials 
Tables 1 and 2 show the formulation and chemical composition of the experimental diets. The 
four experimental diets for the 16 °C and 12 °C trials were isoproteic (i.e., 59% and 57%), 
isolipidic (≈17% and 20%), and isoenergetic (≈21 MJ/kg for both experiments) (Tables 1 and 
2). The diets for the two trials were both formulated to contain similar amounts of all nutrients 
which satisfied the dietary requirement of small fingerling salmon. The ingredients FM and 
FO used in the two trials came from different sources and therefore there were some 
differences in the total quantity of EPA and DHA in their respective diets. The dietary 
treatments tested in both trials consisted of two diets containing low or high levels of FO, and 
two diets containing low or high levels of DHA-CA oil. Within each temperature study, the 
FO-based diets were supplemented with standard (control) canola oil (Crt-CA) to provide a 
similar content of EPA+DHA to the diets containing DHA-CA at 50% and 100% of total oil 
supplementation.   The FA compositions of diets for the two temperature trials are presented 
in Table 3. All diets were produced in four pellet sizes and were used in accordance with 
increasing fish size. Due to the high FM inclusion (79%) and low supplemental oil inclusion 
(7.8%) in the fingerling diet formulations, phytosterols only contributed 8-16% of the total 
sterols (the rest being cholesterol) in the feeds (Table 2). The calculated levels of EPA+DHA 
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2.4.Fish trials at 16 °C and 12 °C  
Atlantic salmon fingerlings with a mean weight of 0.83 gram (± 0.02) were the starting points 
for the 16 °C trial in Australia (CSIRO research facilities, Bribie Island). The Australian 
experimental fish fry was produced in September 2016 by the industry hatchery Salmon 
Enterprises of Tasmania Pty Ltd (Saltas). Atlantic salmon fingerlings with a mean weight of 
2.08 gram (± 0.05) were the starting points for the 12 °C trial in Norway (Nofima research 
facilities Sunndalsøra). The Norwegian experimental fish fry was produced in January 2016 
from the Broodstock population CrossBreed Stofnfiskur by the company SalmoBreed. The 
experimental fish were distributed in 12 tanks, 100 individuals per tank (300L) and 200 
individuals per tank (150L) for the 16 °C and 12 C trials, respectively. The fibreglass tanks 
were equipped with automatic belt feeders. Freshwater at a constant 16 °C (± 0.1) and 12 C 
(± 0.1) was supplied at a flow rate of 3 and 5 l/min, respectively. As the fish grew and oxygen 
consumption increased, flow rate was increased stepwise. Fish were kept under constant light 
(24L:0D) and fed every 10 minutes. Feed was distributed according to the expected growth 
rate and a level of overfeeding that would allow all fish to feed ad lib. The four experimental 
feeds were fed to triplicate groups of fish. Temperature was measured daily in six random 
tanks. 
 
2.5.Fish sampling in the 16 °C and 12 °C trials 
In the 16 C temperature trial, three individual samples of 30 pooled fish were taken initially 
and 100 fish per tank were bulk-weighed (20-30 fish at a time) on the same day. Fish were 
thereafter bulk weighed on day 0, 34, 56, and 70. On day 70, ten fish per tank were sampled 
and pooled for whole body proximal composition and FA analyses and stored at -40°C until 
analyses.  
In the 12 C trial, fish weights were bulk weighed on day 0, 27, 41, and 83. In the final 
sampling, five fish from each tank were sampled for whole body analyses of total lipid and 
FA content and composition. Additionally, five fish per tank were sampled and used for other 
analyses. Blood samples were taken, livers and hearts were dissected out and weighed, and 
organ indices were calculated. Samples of intestine, liver, heart, and red blood cells were 
frozen in liquid nitrogen and stored at -70C until analyses for FA composition, gene 
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2.6.Chemical analysis in the 16 °C and 12 C trials 
Ten fish per tank were used for analyses of carcass chemical composition. Whole fish and dry 
matter content of the feeds were determined by gravimetric analysis following drying at 105 
o
C for 16 h. Ash content was determined based on mass change after combustion in a muffle 
furnace at 550 
o
C for 16 h. Measurement of total nitrogen content was undertaken using an 
elemental analyser (Flash 2000 Thermo Fisher Scientific, USA) and data were used to 
calculate sample protein content based on N x 6.25. Gross energy was determined by 
isoperibolic bomb calorimetry in a Parr 6200 oxygen bomb calorimeter (Par Instrument 
Company, Moline, IL, USA). Carbohydrate was calculated by difference. 
 
2.7.Fat content and fatty acid composition in the 16 °C and 12 C trials 
Total lipids were extracted from the dietary oil, red blood cells, whole body, muscle, liver, 
intestine, and diets following the method described by Folch et al. 
(22)
. For the 16 C 
temperature trial only whole body and diets were analysed. In each dietary group, 15 fish 
were used for lipid analysis (five from each tank). The chloroform-methanol phase after Folch 
extraction was used for the analysis of the FA composition of total lipids using the method 
described by Mason et al. 
(23)
. Briefly, the extract was dried under nitrogen gas, and residual 
lipid was trans-methylated overnight with 2′,2′-dimethoxypropane, methanolic-HCl, and 
benzene at room temperature. The methyl esters were separated and analysed using a gas 
chromatograph (Hewlett Packard 6890; HP, Wilmington, DE, USA) equipped with a split 
injector by using an SGE BPX70 capillary column (length, 60 m; internal diameter, 0.25 mm; 
and film thickness, 0.25 μm; SGE Analytical Science, Milton Keynes, UK), flame ionization 
detector, and HP Chem Station software. The carrier gas was helium, and the injector and 
detector temperatures were both set at 280 °C. The oven temperature was increased from 50 
to 180 °C at the rate of 10 °C/min, and then increased to 240 °C at a rate of 0.7 °C/min. 
Individual FA methyl esters were identified by referring to well-characterised standards. The 
relative amount of each FA was expressed as a percentage of the total amount of FA in the 
analysed sample, and the absolute amount of FA per gram of tissue was calculated using 
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Similar methods were used for the high temperature study and while most FA were the same, 
a few different FA methyl esters were measured in the two standard protocols. In brief, 3 mg 
of oil was esterified using methanol-HCl at 105 °C for 60 min then extracted with hexane for 
separation by gas chromatography (Agilent 6890N), using a DB-23 capillary column (length, 
60 m; internal diameter, 0.25 mm; and film thickness, 0.15 μm). The carrier gas was 
hydrogen. Individual FA methyl esters were identified by referring to well-characterized 
standards and the Agilent RTL FAME Method, relative to C21:0 methyl ester as the internal 
standard. 
 
2.8.Gene expression analysis in the mid-intestine of fish reared at 12 C  
Total RNA was isolated from mid-intestine using PureLink Pro 96 RNA Purification Kit 
(Invitrogen), according to manufacturer's instructions. RNA was treated with PureLink 
DNase1 (ThermoFisher, MA, USA) to remove any contaminating DNA. The RNA 
concentration was measured using a NanoDrop® ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA). Total RNA (900 ng) was reverse-transcribed into 
cDNA in a 20 μl reaction using a TaqMan® reverse transcription reagents kit (Applied 
Biosystems, Foster City, CA, USA) according to the manufacturer's protocol. Quantitative 
PCR was performed in a QuantStudio5 instrument (ThermoFisher, MA, USA), and the PCR 
master mix consisted of 0.5 l forward and 0.5 l reverse primer (Supplementary Table S1, 
final concentrations of 0.5 M), 2 l of a 1:10 dilution of cDNA and 2.5 l PowerUp™ 
SYBR™ Green Master Mix (ThermoFisher, MA, USA). All samples were analysed in 
duplicate with a non-template and non-RT enzyme control for each gene. The reaction was 
performed by incubating the samples at 95 ºC for 20 seconds, forty cycles of 95 ºC for 1 
second, and 60 ºC for 20 seconds. Primer efficiency was evaluated using 10-fold serial 
dilutions of cDNA for each primer pair. The specificity of PCR amplification was confirmed 
by melting curve analysis (95 ºC for 1 second and 60 ºC for 20 seconds, followed by an 
increase of 0.075º per second until 97 ºC). Ef1a, rpol2, and etif3 were evaluated as reference 
genes, and etif3 was identified as the most stable. Relative expressions of mRNA were 
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2.9.Histology of intestine of fish reared at 12 C 
Histological analysis of the mid-intestinal tissue was performed on 15 samples from the mid 
intestine of each dietary group from the low temperature trial, with salmples collected at the 
final sampling, and fixed in 10% phosphate buffered formalin and stored at 4 °C until 
analysis. The samples were dehydrated and processed according to standard protocols. 
Paraplast-embedded samples were cut using a microtome (5 μm) and stained with 
hematoxylin and eosin (Merck KGaA; Darmstadt, Germany). Stained slides were examined 
using a standard Nikon Optiphot light microscope (Nikon, Japan). Images were captured 
using a MicroPublisher 3.3 RTV camera and analysed using QCapture suite software 
(QImaging, Canada). The sections were evaluated in a blinded manner to identify any 
pathological or other systematic variations in tissue morphology.  
 
2.10. Phytosterols, cholesterol, vitamin E, and vitamin K analyses in the 12 °C trial  
Phytosterols and cholesterol were analyzed in the oils, feeds, and in fish liver samples (six 
individual fish per tank with triplicate tanks per diet group), on a GC as described in detail by 
Sissener et al. 
(25)
, based on Laakso 
(26)
. High-performance liquid chromatography (HPLC) 
was used for determination of tocopherols in the oils according to CEN 
(27)
, with two 
analytical parallels. Phylloquinone (vitamin K1), menaquinone (MK4-10, K2), and 
menadione (K3) were analyzed both in the oils and feed samples with four analytical parallels 




2.11. Enzyme activities in the liver from fish reared at 12 °C 
Livers were frozen separately in liquid nitrogen, and subsequently analysed for the activities 
of catalase, glutathione peroxidase, and superoxide dismutase (SOD). The activity of catalase 
was measured according to a method described in Baudhuin et al. 
(29)
. SOD activity 
colorimetric assay kit (Biovision, California, USA) and glutathione peroxidase assay kit 
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enzymes following the manufacturers’ protocol. The enzyme reactions were measured using a 
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2.12. Liver lipidomics in the 12 °C trial 
Liver lipids were extracted in the presence of authentic internal standards by the method of 
Folch et al. 
(22)
 using chloroform:methanol (2:1 v/v). Neutral lipid classes were separated on 
a solvent system consisting of petroleum ether/diethyl ether/acetic acid (80:20:1). 
Phospholipid classes were separated using the Agilent Technologies 1100 Series LC. Each 
lipid class was transesterified in 1% sulfuric acid in methanol in a sealed vial under a 
nitrogen atmosphere at 100 °C for 45 minutes. The resulting FA methyl esters were 
extracted from the mixture with hexane containing 0.05% butylated hydroxytoluene and 
prepared for GC by sealing the hexane extracts under nitrogen. FA methyl esters were 
separated and quantified by capillary GC (Agilent Technologies 6890 Series GC), equipped 
with a 30 m DB 88 capillary column (Agilent Technologies) and a flame ionization detector. 
For detection of ceramides, deuterium-labeled internal standards were added, and samples 
were solubilized in methanol followed by a crash extraction. A bilayer was formed with the 
addition of KCl in water, and the organic layer was removed and concentrated under 
nitrogen. The extract was spun, filtered, and split into two injections; one for ceramides and 
one for sphingosines. The extract was injected onto an Agilent C8 column connected to an 
Agilent 1290 Infinity LC and ABI 4000 QTRAP. The analytes were ionized via positive 
electrospray and the mass spectrometer was operated in the tandem MS mode. The absolute 
concentration of each sphingolipid was determined by comparing the peak to that of the 
relevant internal standard. 
 
2.13.  Liver metabolomics in the 12 °C trial 
The metabolomics work was performed by Metabolon (Durham, NC, USA) as previously 
described 
(30; 31)
 with liver samples sampled from 9 fish from each of the four diet groups. 
Several recovery standards were added for quality control, and samples were prepared using 
the automated MicroLab STAR® system from Hamilton Company.  Proteins were 
precipitated with methanol under vigorous shaking for 2 min (Glen Mills GenoGrinder 2000) 
followed by centrifugation. The resulting extract was analyzed by four different methods; two 
separate reverse phase (RP)/UPLC-MS/MS methods with positive ion mode electrospray 
ionization (ESI), analysis by RP/UPLC-MS/MS with negative ion mode ESI and analysis by 
hydrophilic-interaction chromatography (HILIC)/UPLC-MS/MS with negative ion mode ESI. 
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sample extract was dried before being reconstituted in solvents compatible to each of the 
methods, and each reconstitution solvent contained a series of standards at fixed 
concentrations. All methods utilized a Waters ACQUITY ultra-performance liquid 
chromatography (UPLC) and a Thermo Scientific Q-Exactive high resolution/accurate mass 
spectrometer interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap 
mass analyzer operated at 35,000 mass resolution (further details can be found in the 
references above). Metabolites were identified by automated comparison of the ion features in 
the experimental samples to a reference library of chemical standard entries that included 
retention time, molecular weight (m/z), preferred adducts, and in-source fragments as well as 




2.14. Microarray analysis of liver in the 12 °C trial 
Liver transcriptome was analysed with Nofima’s 44 k microarray Salgeno containing 
oligonucleotide probes to all identified genes of Atlantic salmon. Analyses included all four 
experimental groups with five fish per group, and total 20 arrays were used. Custom 
microarrays were produced by Agilent Technologies and all reagents and equipment were 
purchased from the same provider. One-Color Quick Amp Labelling Kit was used for RNA 
amplification, labelling, and fragmentation of labelled RNA was performed with a Gene 
Expression Hybridization kit. After overnight hybridization in an oven (17 h, 65 °C, rotation 
speed 0.01g), arrays were washed with Gene Expression Wash Buffers 1 and 2 and scanned 
with the Agilent scanner. Nofima’s bioinformatics pipeline STARS was used for data 
processing and mining of results. The high FO group was used as reference. Differentially 
expressed genes (DEG) were selected by lows stringency criteria that are commonly applied 
to feeding trials: log2-Expression Ratio > |0.6| (1.5-fold) and p < 0.05. 
 
2.15. Calculations  
Fish growth rate was calculated as follows, based on mean weights: 
Specific growth rate (SGR) = (e
(lnW1-lnW0)/t
-1)*100  




)*1000/d   
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Hepatosomatic index (HSI) = liver weight / body weight *100; 
Cardiosomatic index (CSI) = heart weight / body weight *100; 
 
2.16. Statistical analyses 
In the 16 °C trial study, tanks were used as experimental units and differences in performance 
were tested by one-way analysis of variance (ANOVA) followed by post-hoc comparisons 
using Tukey-Kramer tests. Before all analyses, the ANOVA assumptions of normality of 
residuals and homogeneity of variances were tested using the Shapiro-Wilk and Levene tests, 
respectively. All analyses were performed using NCSS 11.  
In the 12 °C trial temperature trial, tanks were used as experimental units and the chosen level 
of significance was p < 0.05. Changes in growth, FA compositions, and enzyme activities 
were analysed by one-way ANOVA and Duncan’s multiple range test. The mRNA transcript 
abundance of metabolic relevant genes in the intestine was analysed by one-way ANOVA 
followed by the Tukey’s honest significant difference post hoc test to detect differences 
within dietary groups. These statistical analyses were conducted using the software SAS (SAS 
Institute Inc., Cary, NC, 1989-2007). 
Sterol levels in fish livers were analyzed by nested ANOVA, with tank as random factor and 
diet as fixed factor, conducted in Statistica (version 13.1, Statsoft, Tulsa, OK, USA). For 
statistical analyses of the metabolomics/lipidomics data, any missing values were assumed to 
be below the limits of detection and these values were imputed with the compound minimum 
(minimum value imputation). While the lipidomics data are quantitative, the other metabolites 
are given in relative quantities, and for these the raw data for each biochemical was re-scaled 
to have a median of 1. Statistical analysis of log-transformed data was performed using R 
(http://cran.r-project.org/), which is a freely available, open-source software package. A two-
way ANOVA with contrasts was used to identify statistically significant (p < 0.05) effects of 
oil source (DHA-CA vs FO), effects of inclusion level (high vs low), and interaction between 
oil source and level. Multiple comparisons were accounted for by estimating the false 
discovery rate (q-value < 0.10). In the figures, the lipid metabolites and enzyme activities are 
displayed in Tukey boxplots, showing median, upper and lower quartiles, maximum and 
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3.1.Characterization of DHA-CA and Ctr-CA 
There were major differences in the FA composition of the dietary oils  DHA-CA vs Ctr-CA,  
with lower levels of 18:1n-9 (39% vs 64%) and 18:2n-6 (9% vs 13%) and higher levels of 
18:3n-3 (21% vs 13%) and 22:6n-3 (8.2% vs 0%) occurring in the DHA-CA than in the Ctr-
CA, respectively (Table 3). The DHA-CA also contained 0.4% 20:5n-3 and 0.8% 22:5n-3. In 
addition, the DHA-CA had a higher level of total vitamin E forms compared with the Ctr-CA, 
which was primarily due to an increased level of gamma-tocopherol, with values of 325 mg 
kg 
-1
 in the DHA-CA compared to 282 mg kg 
-1
 in the Ctr-CA. 
A range of undesirables were analyzed in the two canola oils and of the 119 organophosphate 
pesticides, the 30 chlorinated pesticides, and heavy metals, all were below limit of 
quantification (LOQ) in both oils (data not shown). Only compounds often detected in 
commercial oils above the LOQ are shown in Table 3. In general, the undesirables normally 
detected in canola oils used in commercial fish feeds were not detected or were below LOQ in 
the two canola oils (DHA-CA and Ctr-CA) used in the current feeding trials. The profile of 
individual phytosterols differed, with a lower proportion of brassicasterol occurring in the 
phytosterols in the DHA-CA than in Ctr-CA. 
The total content of vitamin K was higher in the DHA-CA with 3.6 mg kg-1, compared to 1.6 
mg kg-1 in the Ctr-CA. In the oils, 0.0-0.1% of total vitamin K was K3, while the remainder 
was K1 (~95% trans-K1 and ~5% cis-K1). 
 
3.2.Composition of fish feeds 
Table 4 shows the FA composition of the diets used in the two temperature trials. When 
exchanging FO with DHA-CA, the typical plant FA 18:1n-9 and 18:2n-6 remained relatively 
similar between the comparable diet groups, but the total saturated fatty acids (SFA), was 
reduced compared to the level of these FA in the corresponding FO diets, while the levels of 
18:3n-3 increased. The sum of EPA+DHA was similar in the two comparable diets (Low FO 
vs Low DHA-CA and High FO vs High DHA-CA), but due to the fact that the DHA-CA oil 
mainly contains DHA and less EPA, the DHA-CA diets contained slightly more DHA and 
less EPA than the corresponding FO diets. There were some differences between the diets for 
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monounsaturated fatty acids (MUFA) and n-6 PUFA were lower in the diets for the 16 °C 
trial compared to the level of these in the diets for the 12 °C trial due to different sources of 
the ingredients FM and FO. 
 
3.3.Fish performance and whole-body composition 
The fish at 16 °C grew from an initial weight of 0.8 g to a final weight of approximately 15.5 
g, while fish in the 12 °C trial grew from 2 g to 24 g, resulting in an ≈20-fold increase in 
weight during the course of the trial at 16 °C and an ≈12-fold increase at 12 °C (Table 5). The 
specific growth rate at 16 °C was 40% higher than at 12 °C. There was no difference in SGR 
or TGC between the dietary groups within each temperature trial. Survival was very high (≥ 
94%) in all groups.   
There were also no differences in proximate whole-body composition (protein, dry matter, 
and ash) and energy content of fish in the different experimental groups in either of the 
experiments (Table 6). However, when salmon were reared at 16 °C, the whole-body lipid 
content was significantly increased in fish fed diets containing the DHA-CA oil compared to 
those fed the FO-diets. 
FA profiles in the whole body of fish from the two temperature experiments are presented in 
Table 7. In general, for both trials, the percentages of SFA were lower and the total n-3 FA 
were higher in both the DHA-CA groups than in the FO groups, reflecting the high 18:3n-3 
content and the lower SFA contents of these diets. The two Low dietary groups (Low FO vs 
Low DHA-CA) and the two High dietary groups (High FO vs High DHA-CA) had similar 
percentages of EPA+DHA in whole body in both trials, although the actual level was higher 
in the low temperature trial due to the higher level occurring in their diets.   
 
3.4. Fat content and fatty acid compositions of erythrocytes and muscle in fish in the 12 °C 
trial. 
There were no significant differences in total lipid content in muscle between the dietary 
groups, with the lipid content (% of wet weight) of approximately 5% in all dietary groups 
(Table 8). The total FA composition of the muscle showed only minor differences in the 
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total n-6 FA were mostly affected by the inclusion level of the oils and only moderately by the 
oil source. Thus, slightly lower percentages of MUFA (≈41% vs 43%) and of n-6 FA (≈5.4% 
vs 6.0%) were observed in the muscle from the High groups compared to those in the Low 
groups. The opposite result was found for the content of total n-3 FA, where the two High 
dietary groups had the highest percentages of n-3 FA (≈29% vs 27%). The percentage of EPA 
was lower in the muscle of the two groups fed the DHA-CA diets compared to the FO diets, 
while 18:3n-3 and DHA were higher. The two Low dietary groups (Low FO vs Low DHA-
CA) had ≈22% and the two High dietary groups (High FO vs High DHA-CA) had  ≈24% and 
22% respectively of EPA+DHA in muscle, showing that the EPA+DHA from the DHA-CA 
oil was incorporated into muscle tissue to approximately the same extent as from FO. 
Total lipid content of erythrocytes was similar in all dietary groups (Table 9).  The 
percentages of SFA were in general higher in the FO groups than in the two DHA-CA groups, 
while the MUFA and total n-6 FA were similar in all diet groups. The total n-3 FA were lower 
in the FO groups relative to their corresponding DHA-CA groups (Low FO vs Low DHA-CA 
and High FO vs High DHA-CA). The increase in total n-3 FA was due to the higher content 
of 18:3n-3 in the erythrocytes from fish fed the DHA-CA diets. Erythrocytes EPA content 
was higher in the FO groups than the DHA-CA groups due to a higher content of EPA in the 
FO diets. However, there was no significant difference in DHA content in erythrocytes of the 
different groups. 
 
3.5.  Liver responses in the fish reared at 12 °C: liver lipids, metabolomics, markers for 
oxidative stress, and transcriptome analysis  
Liver lipids were analyzed both by traditional methods for total lipid, total FA profile, and 
sterol content (Table 10), as well as by lipidomic analysis, the later providing quantitation of 
the total triacylglycerol (TAG) (Figure 1) and determination of how the dietary FA are 
influencing the FA composition of different polar and neutral lipid classes (Figure 2). Table 
10 shows that there were no significant differences in total lipid content in liver between the 
dietary groups. The lipid content (% of wet weight) was 5.8% in the High DHA-CA and 
approximately 6.3% in the other dietary groups. The levels of TAG were affected by the 
inclusion level of the oils, but not by the oil source. Total TAG (p = 0.01, Figure 1) was 
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The total FA composition of the liver (Table 10) showed no difference in the percentage of 
SFA (25% of total FA) between the dietary groups. The percentages of MUFA and total n-6 
FA showed slightly lower percentages of MUFA (≈27% vs 29%) and of n-6 FA (≈5.6% vs 
6.5%) in the High groups compared to the Low groups. The opposite result was found 
regarding the content of total n-3 FA, where the two “High” diets had the highest percentages 
of n-3 FA (≈41% vs 37%). The percentage of EPA was lower in the liver of the two groups 
fed the DHA-CA diets compared to the FO diets, while 18:3n-3 and DHA were higher. The 
two Low dietary groups (Low FO vs Low DHA-CA, ≈34%) and the two High dietary groups 
(High FO vs High DHA-CA, ≈37%) had similar percentages of EPA+DHA in liver. 
Lipidomic analyses did not separate between families of FA, but the FA compositions of 
different polar and neutral lipid classes in the liver were to different degrees affected by the 
dietary oils (Figure 2). The most pronounced effects were seen on the incorporation of 18:3 
FA, with a 2.4-2.9-fold increase in High DHA-CA vs High FO in most lipid classes. The 
proportion of 20:5 FA was decreased in most polar lipids in the liver of fish fed High DHA-
CA vs High FO, with differences from 1.2- to 1.7-fold. 20:4 FA increased in phosphatidyl 
choline (PC) (fold difference 1.3, p-value 0.003), and also in cholesterol ester (CE) and free 
fatty acids (FFA) in fish fed High DHA-CA vs High FO. 22:6 FA was significantly enriched 
in phosphatidylinositol (PI) of fish fed the High DHA-CA vs High FO, and also in CE (both 
1.2-fold difference, p=0.02). Liver cholesterol was similar in all diet groups, while the DHA-
CA dietary groups had increased liver content of phytosterols, primarily campesterol and 
sitostanol (Table 10). 
There were no significant differences in the activities of the key enzymes, catalase, GPX, and 
SOD associated with oxidative stress between the dietary treatments (Figure 3). S-Adenosyl-
L-methionine (SAMe) is also one of the major physiologic protectors against oxidative stress. 
For S-adenosylmethionine (SAM), there was both a diet effect (DHA-CA fed fish livers had 
higher marker levels than FO fed fish livers, p=0.005, q=0.02) and an effect of level (the 
High inclusion level groups had higher than the Low inclusion groups, p=0.006, q=0.05). 
Reduced glutathione (GSH) had a clear effect due to the oil inclusion level, with higher 
metabolite levels at Low inclusion compared to High inclusion (p=0.003, q=0.04), 
irrespective of oil source. The oxidized glutathione was constant (not shown). As oxidized 
glutathione was constant, the ratio of oxidized to reduced glutathione was increased at the 
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The gene expression profiles in livers of salmon fed High DHA-CA and High FO were nearly 
identical. Salmon fed Low FO and Low DHA-CA diets showed highly consistent stimulation 
of genes in lipid and cholesterol metabolism relative to the High groups. Twenty-two up-
regulated DEG encoded 17 proteins with key roles in lipid and cholesterol metabolism (Table 
11). Eighteen genes encode 12 enzymes of terpenoid backbone and steroid biosynthesis 
(diphosphomevalonate decarboxylase, farnesyl diphosphate synthase, 7-dehydrocholesterol 
reductase, isopentenyl-diphosphate delta-isomerase, lanosterol 14-alpha demethylase, 
lanosterol synthase, mevalonate kinase, squalene monooxygenase, squalene synthase, 
stearoyl-CoA desaturase b, sterol-4-alpha-carboxylate 3-dehydrogenase, and sterol-C5-
desaturase). Fatty acid-binding protein is required for transport of highly lipophilic 
compounds, while insulin-induced gene 1 and lipin control steroid and fatty acid metabolism 
at different levels. The expression differences of genes involved in lipid and steroid 
metabolism were related to the levels of n-3 LC-PUFA in the diets, but not to the source of 
these FA as shown in Table 11. The microarray analysis revealed no significant differences in 
transcription of genes associated with stress, apoptosis, inflammation, xenobiotic metabolism, 
or any other processes that might indicate adverse effects of the diets (data not shown).   
 
3.6.Gene expression and histological analyses of the intestine. 
The histological analyses of intestinal morphology revealed no differences between the 
dietary groups (data not shown). Gene expression analysis of intestine tissue did not show any 
significant differences in expression of markers for fatty acid oxidation (aco, cpt1), fatty acid 
synthesis (fas, scd1, scd2), stress (hsp70), inflammation (cox2), or oxidative stress (nrf2, cat, 
sod1s, gpx2) between FO and DHA-CA for either the Low or the High groups. The High 
DHA-CA had a small, but significantly higher expression level of the apoptosis marker bax 
compared to the High FO group (Supplementary Table S2).  
 
4. Discussion 
The major overall aim of the two fish feeding trials was to rigorously investigate the 
suitability and possible fish health safety risk associated with the use of oil from a newly 
developed genetically modified canola crop (DHA-CA) as an omega-3 FA source in feed for 
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sources of raw ingredients to provide a robust assessment of DHA-CA in varying 
experimental conditions. Very small fingerlings were chosen as the target life stage as they 
undergo extremely rapid growth and are highly responsive to dietary changes due to their 
heightened sensitivity. 
   
Influence of DHA-CA on culture performance 
The experimental fish showed a 12- and 20-fold increase in body weights at 12 °C and 16 °C, 
respectively, over the course of both experiments. The SGR was higher in the high 
temperature experiment, with Australian strains adapted to warm water conditions. TGC 
indicated both cohorts grew similarly well at their respective temperatures. The DHA-CA 
groups, relative to the corresponding FO groups, grew equally well with high survival rates 
(≥94%) achieved in both experiments. 
 
Influence of DHA-CA on salmon health and safety 
 Intestine and liver are particularly sensitive organs to harmful effects.  The expression of 
genes associated with stress or toxicity, or enzyme activities related to oxidative stress, were 
not affected in fish fed DHA-CA. The moderate effects observed in these organs were 
primarily due to the inclusion level of the oil in the diet and not to the oil source, results 
which further strengthen the fact that our trial could not reveal any major fish health risk 
associated with inclusion of DHA-CA in salmon diets. This is in agreement with studies 
showing that both a high-EPA oil  and an EPA+DHA oil from transgenic Camelina sativa 
included in feeds for post-smolt Atlantic salmon had no detrimental effects on fish 
performance, metabolic responses or the nutritional quality of fillet 
(17; 33)
.  
The analysed composition of the DHA-CA oil in our trial compared to a conventional canola 
oil showed that it contained very low levels of undesirables, with levels measured far below 
LOQ (limit of quantification) of pesticides, mycotoxins, heavy metals, and PAH. Further, 
DHA-CA also had lower levels of the typical plant oil FA - 18:1n-9 and 18:2 n-6 – compared 
with a conventional canola oil and higher levels of ɣ-tocopherol and the health-beneficial n-3 
FA - 18:3n-3 and DHA. Overall, these results show that the DHA-CA oil has a nutritionally 
beneficial composition compared to conventional canola oils in line with other n-3 rich oils 
derived from newly developed transgenic plant crops as reviewed by Tocher et al. 
(34)
. The 
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negative effects on fish performance and health were found, even at high inclusion levels. The 
vitamin E (particularly ɣ-tocopherol) differed between DHA-CA and Ctr-CA, however, both 
oils were well within the normal range given for the different vitamin E isomers in 




Influence of DHA-CA on composition of whole body, muscle, and erythrocytes 
The study showed no major differences in total lipid, protein, or energy content of the whole 
body of fish in the various dietary groups, while the FA compositions were affected. 
Generally, for both temperature trials, lower percentages of both SFA and MUFA and higher 
percentages of 18:3n-3 and DHA were found in whole body of DHA-CA groups compared to 
the FO groups, reflecting the FA compositions of the diets. The level of EPA was moderately 
reduced with increased dietary inclusion of DHA-CA in the diet, due to the lower levels of 
this FA in DHA-CA oil. Overall, the results showed that the comparable Low FO vs Low 
DHA-CA and the High FO vs High DHA-CA diets resulted in equal percentages of 
EPA+DHA in the whole body, showing that the fish could equally utilise the EPA and DHA 
from traditional FO and from the DHA-CA oil. This is also in agreement with what has been 
observed with the EPA rich oil and the EPA+DHA rich oil from Camelina sativa 
(33; 36)
.  
An additional benefit of DHA-CA compared to conventional canola oil is the lower levels of 
n-6 FA, which results in lower body levels of n-6 FA when included in the diet. The n-6 FA 
are linked to pro-inflammatory pathways and generally tend to bio-accumulate with the use of 
terrestrial plant oils to replace fish oil 
(37)
. The muscle tissue showed similar trends to the fatty 
acid profiles of those of the whole body, except for lower relative percentages of MUFA and 
higher percentages of n-3 PUFA. This indicates the fish fillet FA profile is potentially of 
greater nutritional benefit to human nutrition as a result feeding DHA-CA rather than a more 
conventional mixture of canola oil and fish oil.  
The different dietary groups had only minor differences in their FA composition of red blood 
cells, showing that the erythrocytes are less affected by the dietary FA than whole body and 
muscle. There were no significant differences in the EPA+DHA content or total n-6 FA 
content between any of the dietary groups in red blood cells, the most marked effect was 
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Response of liver to DHA-CA 
Previous data have shown that genetic modification of canola can give large unintended 
effects on phytosterol composition (both increase and decrease) 
(38)
. Results from our study 
show that dietary DHA-CA oil results in a 10-30% higher level of phytosterols in liver than 
occurs in the comparable FO-fed groups. However, a recent feeding trial with Atlantic salmon 
fed diets with added different phytosterol levels, showed no negative effect of phytosterols up 




. In our study, the highest dietary level with the highest dose of 
DHA-CA was 739 kg
-1
 feed, showing that no negative effects due to increased phytosterol in 
diet or in the liver would be expected. There was a moderately lower level of cholesterol in 
the diets containing the DHA-CA than in the two FO diets, however, the gene expression 
results from livers showed  that a relatively large number of genes in the sterol biosynthesis, 
among them several genes with important roles in cholesterol synthesis, including lanosterol 
synthase, squalene synthase, and sterol-4-αcarboxylate-3 dehydrogenase, were up-regulated in 
both the Low FO and Low DHA-CA groups compared to the two High groups, indicating that 
it is not the cholesterol level in the diet that effects the expression of these genes in liver in 
our study, rather the n-3- LC PUFA levels. This is contradictory to studies showing that the 
cholesterol synthesis in Atlantic salmon is regulated by the dietary content of cholesterol, i.e. 
high dietary levels able to inhibit and low dietary levels able to stimulate cholesterol synthesis  
(40)
. However, other factors may also influence cholesterol metabolism. In line with our 
findings, previous mammalian studies have reported that EPA and DHA have hypo-




The FA that varied the most in the liver total lipids between the four experimental dietary 
groups was 18:3n-3 (from 0.8-12.4% of total FA), and this was also reflected in the different 
lipid classes, with 18:3 enriched in most liver lipid classes in fish fed the DHA-CA dietary 
groups compared to the FO groups. While EPA+DHA was well balanced between DHA-CA 
diets and their corresponding FO control groups, the DHA/EPA ratio was higher in the DHA-
CA dietary groups. Hence, 20:5 FA decreased in the cell membrane PLs phosphatidyl choline 
(PC), phosphatidylethanolamine (PE), lyso phosphatidyl choline (LPC), cholesterol ester (CE) 
and TAG in the livers of fish fed the DHA-CA diets. DHA increased primarily in CE and PI. 
In the current diets, formulated for small fish, a high proportion of LC-PUFA was also 
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all feeds above requirements. The FA 20:3 increased in most lipid classes. Although the lipid 
class analyses do not separate between FA families, this is probably the elongation product 
from 18:3n-3 to 20:3n-3, since this FA also increases in the total lipid fraction.  
There were no significant differences in the total lipid level in the liver, while total TAG was 
moderately lower in both the high inclusion level of LC-PUFA irrespective of source. This is 
opposite to earlier findings with EPA rich oil from Camelina sativa in salmon diets which 
resulted in a moderate increase in liver TAG 
(33)
. However several studies have shown that a 
FO rich in EPA and DHA results in decreased TAG level in liver when compared to a diet 
rich in plant oil, in line with our findings here 
(5; 42)
. A factor could be 18:1n-9, which was 
higher in the two feeds with low oil levels (Low FO and Low DHA-CA) compared to the two 
feeds with high oil levels (High FO and High DHA-CA) and has in previous trials/cell trials 
been implicated in liver lipid accumulation 
(43)
. These data indicate a positive effect on fish 
liver health and metabolism of a high inclusion level of LC-PUFA, irrespective of whether 
this source is FO or DHA-CA.  
 
Conclusions 
Our results show that the newly developed modified canola oil (DHA-CA) has a beneficial 
FA profile compared to conventional plant oils, with particularly high levels of the n-3 FAs - 
18:3 n-3 and DHA. Levels of phytosterols, vitamin E, and minerals in the n-3 modified canola 
oil fall within the natural variation of commercial canola oils. Levels of undesirable 
compounds were undetectable.    
Two feed trials have been carried out with salmon in fresh water, the purpose of which has 
been to evaluate the suitability and safety associated with the use of n-3 rich modified canola 
oil on fish performance, composition, and health at two water temperatures. The fish 
increased their weight approx. 20-fold at 16 °C and 12-fold at 12 ° C. Both experiments 
showed high survival across all dietary groups and corresponding growth in salmon fed with a 
FO diet to salmon fed n-3 modified canola oil. The salmon fed the n-3 modified canola oil 
had the same EPA+DHA content and proportional (%) level in the whole body as salmon fed 
FO. The level of oil in the experimental feeds was the main factor affecting differential 
expression of genes and not the source of the oil. The level of oil in the feeds was also the 
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the source of the oil. Based on the current studies it is concluded that the n-3 rich modified 
canola oil (DHA-CA) is as safe as other commercial canola oils and is suitable as an 
alternative oil source in salmon diets. 
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Figure 1. Total triacylglycerol (TAG) in liver from salmon fed the four different diets (n = 9 
per diet group). TAG is given as nmol/g liver tissue, and the figure is a Tukey boxplot, 
showing the median, the interquartile range and the min/max, excluding outliers (which is 
indicated by a triangle). Two-way ANOVA showed significant difference (p = 0.01, q = 0.07) 
between the two inclusion levels (High vs Low) of transgenic canola (DHA-CA) in the diet. 
Between the individual diet groups, there was a significant difference between High FO and 
Low DHA-CA (indicated by letters in the figure, p = 0.005, q = 0.02). 
Figure 2. Overall differences in composition of polyunsaturated fatty acids in the different 
lipid classes in fish fed a diet containing high levels of an n-3 rich modified canola oil (High 
DHA-CA; blue = enriched in this group) versus in fish fed a diet containing high levels of fish 
oil  (High FO; red =  enriched in this group). Colour indicates a significant difference (p < 
0.05) between the two diet groups. The color intensity shows the fold difference (white = not 
significant, grey = not detected). 
Figure 3. Differences between the two inclusion levels (High vs Low) of transgenic canola 
(DHA-CA) in the diet. Upper panel shows the activities of three enzymes involved in the 
oxidative stress response in liver, superoxide dismutase (SOD), catalase and glutathione 
peroxidase (GPX). Lower panels show the level of two metabolites related to redox 
management - SAM and GSH and are given as relative quantities. The graphs are Tukey 
boxplots, showing the median, the interquartile range and the min/max, excluding outliers 
(which is indicated by a triangle), n =9 per diet group. For SAM, two-way ANOVA showed 
significant difference (p = 0.006, q = 0.05) between the two inclusion levels (High vs Low) of 
transgenic canola (DHA-CA) in the diet. Between the individual diet groups, there was a 
significant difference between Low FO and High DHA-CA (indicated by letters in the figure, 
p = 0.0002, q = 0.004). Similarly, for GSH, two-way ANOVA showed significant difference 
(p = 0.003, q = 0.04) between the two inclusion levels. Between the individual diet groups, 
there was a significant difference between Low FO and High DHA-CA (indicated by letters in 
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Table 1. Formulation and composition of the experimental diets used in the 16 °C water 
temperature experiment 
  
  LOW FO HIGH FO LOW DHA-CA HIGH DHA-CA 
Formulation, % 
    
Fish meal 
 79.00 79.00 79.00 79.00 
Wheat 
 7.00 7.00 7.00 7.00 
Mineral mix 
 0.59 0.59 0.59 0.59 
Vitamin mix 
 1.92 1.92 1.92 1.92 
Carophyll Pink 
 0.01 0.01 0.01 0.01 
Choline chloride
 0.5 0.5 0.5 0.5 
Vitamin C 
 0.14 0.14 0.14 0.14 
Vitamin E (50%) 0.03 0.03 0.03 0.03 
CaHPO4 1.00 1.00 1.00 1.00 
Betaine 
 1.00 1.00 1.00 1.00 
Soy lecithin 
 1.00 1.00 1.00 1.00 
Tuna oil (TO)
 1.6 3.2 - - 
Control canola oil 
 6.2 4.6 3.9 0.00 
DHA-CA 
 - - 3.9 7.8 
Origin of EPA+DHA, % in diet 
    
Fish meal (FM) 1.90 1.90 1.90 1.90 
TO 0.47 0.95 - - 
DHA-CA - - 0.47 0.94 
Chemical composition: 
    
Dry matter 94.2 94.2 93.1 94.0 
Fat 16.2 16.2 16.7 17.0 
Protein 58.7 59.6 60.0 58.7 
Ash 11.7 11.6 11.7 11.8 
Gross energy (MJ kg
-1
) 21.4 21.5 21.6 21.5 
All ingredients were sourced from an Australian provider. The fishmeal used was commercial fishmeal from 
South America (Peru & Chile) provided by Ridley Aquafeeds. The source of fish oil was tuna oil in order to 
more closely match the balance of EPA:DHA in control and test feeds. Feed pellets (three class sizes; 0.5-1.0 
mm, 1.0-1.4 mm, and 1.4-2.0 mm) were prepared at the CSIRO Bribie Island Research Centre. QLD. The 
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Table 2. Formulation and composition of the experimental diets used in the 12 °C water 
temperature experiment 
  LOW FO HIGH FO LOW DHA-CA HIGH DHA-CA 
Formulation, % 
    
Fish meal 
1 79.00 79.00 79.00 79.00 
Wheat 
2 7.50 7.50 7.50 7.50 
Mineral mix 
3 0.52 0.52 0.52 0.52 
Vitamin mix 
4 2.00 2.00 2.00 2.00 
Monoammonium phosphate 
5 1.00 1.00 1.00 1.00 
Carophyll Pink 
6 0.01 0.01 0.01 0.01 
Vitamin D3. IU/g 
7 2.0 2.0 2.0 2.0 
Vitamin E 
8 0.03 0.03 0.03 0.03 
Vitamin C 
9 0.14 0.14 0.14 0.14 
Betafin 
10 1.00 1.00 1.00 1.00 
Soy lecithin 
11 1.00 1.00 1.00 1.00 
Fish oil 
12 1.72 3.41 0.00 0.00 
Control canola oil 
13 6.08 4.39 3.88 0.00 
DHA-CA 
 0.00 0.00 3.92 7.79 
Origin of EPA+DHA, % in diet 
    
Fish meal 1.62 1.62 1.62 1.62 
Fish oil 0.32 0.63 0.00 0.00 
DHA-CA 0.00 0.00 0.32 0.63 
Chemical composition 
    
Dry matter 93.9 93.7 93.8 93.7 
Fat 20.9 20.6 20.9 20.7 
Protein 56.8 56.3 56.4 56.6 
Ash 13.4 13.3 13.3 13.2 
Gross energy (MJ kg
-1
) 20.9 21.0 21.0 21.0 
Sterol composition     
Cholesterol (mg kg
-1
) 4227 4469 4028 3950 
Sum phytosterols (mg kg
-1
) 497 378 671 739 
Campesterol (% of sum phyto.) 32.8 31.0 33.7 35.4 
β-sitosterol (% of sum phyto.) 48.6 48.6 48.1 45.5 
Brassicasterol (% of sum phyto.) 3.3 4.4 2.3 2.0 
Vitamin K isomers (mg kg
-1
)     
Phylloquinone (vit K1) 0.05 0.04 0.10 0.14 
Menaquinone (vit K2) 0.07 0.07 0.06 0.06 
Menadione (K3) 5.91 5.79 5.84 5.94 
1Nordsildmel. 
2Norgesmøllene. 
3Individual minerals purchased from Vilomix and mixed by Nofima.     
4-10 Vilomix.  
11Denofa.  
12Nordsildmel.  
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Table 3. Selected undesirables, phytosterols, vitamin E isomers, and fatty acids in the n-3 rich 
modified canola oil (DHA-CA) and the control canola oil (Ctr-CA). 
 DHA-CA Ctr-CA 
Heavy metals (mg kg
-1
)  
Total arsenic <0.009 <0.009 
Polyaromatic hydrocarbons (µg kg
-1
)  
Benzo(a)antracene  <0.5 <0.5 
Benzo(a)pyrene <0.5 <0.5 
Benzo(b)fluoranthene <0.5 <0.5 
Chrysene  <0.5 <0.5 
Organophsophate pesticides (µg kg
-1
)  
Pirimiphos-methyl  <20 <20 
Lipid-soluble mycotoxins (µg kg
-1
)  
Enniatin B <10 <10 
Phytosterols  
Sum phytosterols (mg kg
-1
) 9659 7878 
Campesterol (% of sum) 39.6 34.2 
β-sitosterol (% of sum) 43.0 44.5 
Brassicasterol (% of sum) 3.5 12.2 
Vitamin E isomers (mg kg
-1
)   
Alfa-tocopherol 200 188 
Gamma-tocopherol 330 283 
Delta-tocopherol 6.7 6.9 
Beta-tocotrienol 95 71 
Vitamin K isomers (mg kg
-1
)   
Phylloquinone (vit K1) 3.62 1.61 
Menaquinone (vit K2) 0.00 0.00 
Menadione (K3) 0.00 0.00 
Fatty acid composition (%)   
16:0   4.6 3.9 
18:0 1.9 1.6 
Ʃ SFA
1
 7.4 6.7 
18:1n-9 38.7 63.6 




18:2n-6 9.0 13.1 
18:3n-3 20.9 10.3 
20:5n-3 0.4 0.1 
22:5n-3 0.8 nd 




Ʃ n-6 10.0 13.3 
Ʃ n-3 30.6 10.4 
nd, not detectable levels.  
1Includes 14:0, 17:0, 20:0, 22:0, and 24:0. 
2Includes 16:1n-9, 20:1n-9, 20:1n-11, 22:1n-7, and 24:1n-9. 
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Table 4. Fatty acid composition (% of total fatty acids) of the experimental feeds  
 16 °C WATER TEMPERATURE TRIAL  12 °C WATER TEMPERATURE TRIAL 
  LOW FO HIGH FO LOW DHA-CA HIGH DHA-CA  LOW FO HIGH FO LOW DHA-CA HIGH DHA-CA 
14:0 4.1 4.5 3.7 3.7  3.7 4.3 3.1 3.2 
16:0   16.4 18.4 14.8 15.0  11.2 12.2 10.4 10.6 
18:0 3.4 3.9 3.2 3.3  1.9 2.1 2.0 2.0 
20:0 0.3 0.3 0.3 0.2  0.3 0.3 0.4 0.4 
Ʃ SFA
1 27.2 30.5 23.9 23.5  17.7 19.7 16.6 16.8 
16:1n-7 4.3 4.8 3.8 3.9  2.6 3.1 2.0 2.1 
18:1n-7 3.0 3.0 3.0 3.0  2.7 2.5 3.0 3.2 
18:1n-9 34.2 28.8 32.9 26.7  29.8 23.6 29.7 24.2 
20:1n-9    1.6 1.6 1.6 1.6  5.8 6.3 5.0 5.1 
22:1n-11 nd nd nd nd  9.2 10.3 7.7 7.8 
Ʃ MUFA
2 
44.0 39.0 42.1 35.9  52.2 49.1 49.8 44.8 
18:2n-6 7.7 6.7 7.8 7  6.5 5.2 6.6 5.7 
20:4n-6 0.5 0.6 0.3 0.3  0.3 0.4 0.3 0.3 
Ʃ n-6
3 
8.5 8.0 8.5 8.0  7.1 5.9 7.4 6.6 
18:3n-3 4.0 3.3 7.8 10.9  4.4 3.4 7.8 10.2 
18:4n-3 1.1 1.2 1.6 2.2  0.2 0.2 0.2 0.2 
20:4n-3 0.3 0.3 0.5 0.9  1.4 1.8 1.4 1.8 
20:5n-3 7.0 7.5 6.7 6.8  5.0 6.2 3.9 4.0 
22:5n-3 0.2 0.2 1.0 1.7  0.6 0.7 0.7 0.8 
22:6n-3 7.5 9.9 7.4 9.6  8.1 8.7 9.0 11.0 
Ʃ n-3
4 
22.4 25.0 27.7 34.8  19.7 20.9 23.2 28.4 
EPA+DHA 17.0 20.5 17.0 19.4  13.1 14.9 13.0 15.0 
nd, not determined  
1Includes 15:0, 17:0, 19:0, 22:0, and 24:0. 
2Includes 14:1n-5, 16:1n-5, 17:1-n7, 18:1n-11, 22:1n-7, 22:1n-9, and 24:1n-9. 
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Table 5. Growth and survival over the experimental period. Data are shown as mean values using tank as a statistical unit (n = 3) with their 
standard errors.  
 
 16 °C WATER TEMPERATURE TRIAL  12 °C WATER TEMPERATURE TRIAL 














Body weight, g           
Day 0 0.83 ± 0.01 0.84 ± 0.02 0.86 ± 0.03 0.83 ± 0.02 0.74  2.04 ± 0.09 2.16 ± 0.04 2.08 ± 0.04 2.05 ± 0.01 0.46 
Period 1 4.63 ± 0.12 4.49 ± 0.06 4.49 ± 0.14 4.44±0.13 0.68  4.47 ± 0.19 4.79 ± 0.07 4.52 ± 0.10 4.38 ± 0.03 0.14 
Period 2 10.35 ± 0.08 10.14 ± 0.28 10.17 ± 0.09 9.94 ± 0.20 0.48  6.82 ± 0.29 7.33 ± 0.10 6.81 ± 0.16 6.67 ± 0.03 0.11 
Period 3 15.49 ± 0.47 15.29 ± 0.31 16.22 ± 0.77 15.25 ± 0.22 0.47  23.82 ± 0.94 25.41 ± 0.80 23.28 ± 0.62 23.74 ± 1.02 0.38 
SGR (% d
-1
)           
Period 1 5.04 ± 0.09 4.94 ± 0.02 4.90 ± 0.04 4.94 ± 0.03 0.18  2.95 ± 0.03 3.01 ± 0.12 2.93 ± 0.07 2.87 ± 0.03 0.64 
Period 2 3.66 ± 0.08 3.72 ± 0.05 3.73 ± 0.10 3.67 ± 0.06 0.90  3.05 ± 0.03 3.08 ± 0.03 2.97 ± 0.07 3.03 ± 0.08 0.57 
Period 3 2.87 ± 0.26 2.91 ± 0.12 3.18 ± 0.20 3.06 ± 0.04 0.65  3.02 ± 0.03 3.00 ± 0.05 2.97 ± 0.01 3.07 ± 0.11 0.73 
SGR total 4.17 ± 0.04 4.20 ± 0.02 4.20 ± 0.02 4.16 ± 0.02 0.72  3.01 ± 0.01 3.02 ± 0.07 2.96 ± 0.02 3.00 ± 0.04 0.76 
TGC total 1.36 ± 0.02 1.35 ± 0.01 1.38 ± 0.027 1.35 ± 0.00 0.73  1.59 ± 0.02 1.63 ± 0.04 1.57 ± 0.02 1.59 ± 0.04 0.50 
Survival (%) 99.7 ± 0.40 99.0 ± 0.40 98.0 ± 0.49 99.3 ± 0.40 0.14  97.2 ± 1.2 97.0 ± 1.5 96.7 ± 1.4 93.7 ± 3.0 0.55 
The period from 0 to 34 days is denoted Period 1, from 34 to 56 days is denoted Period 2, and from day 56 to 70 days is denoted Period 3 in the 16 °C trial. The period from 0 
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Table 6. Proximate composition and energy content of whole fish at the end of the experiment. Data are shown as mean values using tank as a 
statistical unit (n = 3, being each sample represented by a pool of five fish) with their standard errors. Different superscript letters indicate 
statistically significant differences (p<0.05).  
 
 16 °C WATER TEMPERATURE TRIAL  12 °C WATER TEMPERATURE TRIAL 














Dry matter 25.9 ± 0.55 25.8 ±0.66 27.3 ± 0.3 27.3 ± 0.20 0.09  27.2 ± 0.36 27.6 ±0.15 27.1 ± 0.06 27.2 ± 0.18 0.43 
Protein 15.3 ± 0.36 15.6 ± 0.61 16.2 ± 0.22 15.8 ± 0.17 0.6  16.1 ± 0.05 16.2 ±0.07 16.4 ± 0.19 16.1 ± 0.07 0.16 
Lipid 9.6 ± 0.31a 9.5 ± 0.13a 10.6 ± 0.28b 10.9 ± 0.40b 0.03  10.7 ± 0.53 11.0 ± 0.15 10.4 ± 0.07 10.4 ± 0.09 0.44 
Ash 1.6 ± 0.07 1.6 ± 0.09 1.5 ± 0.08 1.6 ± 0.07 0.87  2.4 ± 0.06 2.4 ± 0.06 2.4 ± 0.15 2.3 ± 0.06 0.74 
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Table 7. Fatty acid composition (% of total) in the whole body of Atlantic salmon fed the experimental diets for 70 days at high (16°C) and low 
(12°C) water temperature. Data are shown as mean values using tank as a statistical unit (n = 3, being each sample represented by a pool of five 
fish) with their standard errors. Different superscript letters indicate statistically significant differences (p<0.05). 
 16 °C WATER TEMPERATURE TRIAL  12 °C WATER TEMPERATURE TRIAL 







 LOW FO HIGH FO 
LOW   
DHA-CA 




14:0 3.7 ± 0.02a 4.05 ± 0.03b 3.4 ± 0.03c 3.5 ± 0.02c < .001  3.4 ± 0.03b 3.9 ± 0.09a 3.0 ± 0.03c 3.0 ± 0.03c < .0001 
16:0   17.0 ± 0.13a 18.5 ± 0.17b 15.8 ± 0.10c 16.0 ± 0.12c < .0001  13.0 ± 0.03b 13.7 ± 0.03a 12.2 ± 0.23c 12.1 ± 0.03c < .0001 
18:0 4.3 ± 0.05a 4.7 ± 0.01b 4.2 ± 0.01a 4.3 ± 0.05a < .001  2.9 ± 0.03 2.9 ± 0.03 2.9 ± 0.03 3.0 ± 0.03 0.44 
20:0 0.3 ± 0.00a 0.3 ± 0.00b 0.3 ± 0.00a 0.3 ± 0.00a < .001  0.3 ± 0.00 0.3 ± 0.03 0.3 ± 0.03 0.3 ± 0.00 0.33 
Ʃ SFA
1
 26.3 ± 0.18
a 28.8 ± 0.22b 24.8 ± 0.20c 25.1 ± 0.13c < .0001  20.0 ± 0.06b 21.3 ± 0.13a 18.9 ± 0.30c 19.0 ± 0.07c < .0001 
16:1n-7 4.0 ± 0.05a 4.5 ± 0.03b 3.7 ± 0.03c 3.7 ± 0.01c < .0001  3.2 ± 0.15b 3.6 ± 0.10a 2.3 ± 0.09c 2.2 ± 0.00c < .0001 
18:1n-7 3.4 ± 0.01a 3.4 ± 0.01a 3.3 ± 0.02b 3.3 ± 0.01b < .01  3.7 ± 0.07c 3.6 ± 0.00c 4.0 ± 0.03b 4.3 ± 0.03a < .0001 
18:1n-9 34.9 ± 0.16a 30.3 ± 0.20b 34.0 ± 0.07c 28.2 ± 0.09d < .0001  31.6 ± 0.20a 26.7 ± 0.20b 31.3 ± 0.12a 26.2 ± 0.07b < .0001 
20:1n-9    2.4 ± 0.01a 2.2 ± 0.03b 2.3 ± 0.03c 2.1 ± 0.00d <.0001  6.3 ± 0.06b 6.8 ± 0.03a 5.6 ± 0.03c 5.4 ± 0.00d < .0001 




a 41.4 ± 0.252b 44.2 ± 0.11c 38.1 ± 0.09d < .0001  54.0 ± 0.23a 51.3 ± 0.26b 51.9 ± 0.18b 47.8 ± 0.09c < .0001 
18:2n-6 6.4 ± 0.05a 5.7 ± 0.03b 6.4 ± 0.03a 5.9 ± 0.07c < .0001  5.4 ± 0.06a 4.5 ± 0.00c 5.5 ± 0.10a 4.9 ± 0.00b < .0001 




a 7.3 ± 0.11b 7.6 ± 0.03a 7.1 ± 0.11b < .0001  6.8 ± 0.03a 5.9 ± 0.09c 6.9 ± 0.09a 6.4 ± 0.03b < .0001 
18:3n-3 3.1 ± 0.05a 2.6 ± 0.06b 5.9 ± 0.02c 8.5 ± 0.12d < .0001  3.2 ± 0.06c 2.6 ± 0.00d 5.7 ± 0.10b 7.8 ± 0.03a < .0001 
18:4n-3 0.9 ± 0.01a 0.9 ± 0.01a 1.3 ± 0.01b 1.8 ± 0.03c < .0001  nd nd nd nd  
20:3n-3 0.2 ± 0.00a 0.2 ± 0.00b 0.5 ± 0.00c 0.7 ± 0.00d < .0001  0.2 ± 0.00b 0.2 ± 0.00b 0.5 ± 0.03a 0.6 ± 0.12a 0.003 
20:4n-3 0.5 ± 0.00a 0.5 ± 0.01a 0.8 ± 0.00b 1.2 ± 0.00c <0.001  0.6 ± 0.09b 0.8 ± 0.01a 0.6 ± 0.01b 0.6 ± 0.00b 0.02 
20:5n-3 3.0 ± 0.05a 3.2 ± 0.03b 2.9 ± 0.02a 3.2 ± 0.04c < .0001  2.8 ± 0.00b 3.5 ± 0.03a 2.4 ± 0.00c 2.5 ± 0.03c < .0001 
22:5n-3 1.4 ± 0.00 1.5 ± 0.02 1.2 ± 0.21 1.4 ± 0.23 0.55  0.9 ± 0.03b 1.2 ± 0.00a 0.9 ± 0.03b 0.9 ± 0.03b 0.0002 




a 22.6 ± 0.22b 23.7 ± 0.23b 29.9 ± 0.09c < .0001  17.6 ± 0.15d 19.3 ± 0.20c 20.6 ± 0.23b 24.7 ± 0.17a < .0001 
n-6/n-3 0.38 ± 0.00a 0.32 ± 0.00b 0.32 ± 0.00b 0.24 ± 0.00c <0.001  0.38 ± 0.00a 0.31 ± 0.00c 0.33 ± 0.01b 0.26 ± 0.00d < .0001 
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nd, not determined. 
1Includes 15:0, 17:0, 19:0, and 21:0. 
2Includes 17:1, 20:1n-7, 20:1n-11, 22:1n-7, 22:1n-9, and 24:1n-9.  
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Table 8. Lipid content (% of wet weight) and fatty acid composition (% of total) in the muscle 
of Atlantic salmon fed the experimental diets for 70 days at low (12°C) water temperature. 
Data are shown as mean values using tank as a statistical unit (n = 3, being each sample 
represented by a pool of five fish) with their standard errors. Different superscript letters 
indicate statistically significant differences (p < 0.05). 
 
  LOW FO HIGH FO LOW DHA-CA HIGH DHA-CA ANOVA p-value 
Total fat 5.0 ± 0.14 5.3 ± 0.18 4.7 ± 0.32 5.5 ± 0.20 0.12 
14:0 3.4 ± 0.02b 3.8 ± 0.02a 3.1 ± 0.17c 2.9 ± 0.01c 0.0004 
16:0   13.7 ± 0.07ab 14.2 ± 0.22a 13.2 ± 0.29b 13.1 ± 0.06b 0.01 
18:0 2.7 ± 0.04 2.6 ± 0.39 2.7 ± 0.03 2.9 ± 0.06 0.76 
20:0 1.1 ± 0.02c 1.3 ± 0.01b 1.3 ± 0.02b 1.6 ± 0.06a < .0001 
Ʃ SFA
1 
21.5 ± 0.10ab 22.5 ± 0.48a 20.8 ± 0.44b 20.9 ± 0.16b 0.03 
16:1n-7 2.6 ± 0.03ab 3.0 ± 0.05a 2.3 ± 0.31b 2.1 ± 0.03b 0.03 
18:1n-9 29.5 ± 0.43a 25.3 ± 0.21b 28.5 ± 1.11a 27.2 ± 0.71ab 0.01 
18:1n-7 3.9 ± 0.36 3.6 ± 0.45 4.1 ± 0.92 3.4 ± 0.41 0.85 
20:1n-9    6.3 ± 0.01b 7.1 ± 0.08a 6.0 ± 0.20bc 5.6 ± 0.20c 0.0006 
22:1n-11 0.8 ± 0.03c 0.9 ± 0.01bc 1.0 ± 0.04b 1.2 ± 0.07a 0.0007 
Ʃ MUFA
2 44.1 ± 0.31a 41.2 ± 0.44bc 42.7 ± 0.09ab 40.6 ± 0.83c 0.005 
18:2n-6 5.1 ± 0.03a 4.3 ± 0.02c 5.1 ± 0.16a 4.7 ± 0.12b 0.001 
20:2n-6 0.4 ± 0.00 0.4 ± 0.02 0.5 ± 0.02 0.4 ± 0.02 0.19 
20:4n-6 0.3 ± 0.01b 0.2 ± 0.00c 0.3 ± 0.01ab 0.3 ± 0.00a 0.0006 
Ʃ n-6
3 5.9 ± 0.03a 5.1 ± 0.06b 6.0 ± 0.17a 5.6 ± 0.15a 0.003 
18:3n-3 3.2 ± 0.05c 2.7 ± 0.03c 5.1 ± 0.50b 7.2 ± 0.31a < .0001 
20:3n-3 0.3 ± 0.01c 0.3 ± 0.00c 0.5 ± 0.06b 0.7 ± 0.03a < .0001 
20:5n-3 9.1 ± 0.09b 10.8 ± 0.04a 8.4 ± 0.47bc 7.9 ± 0.15c 0.0002 
22:5n-3 1.1 ± 0.06 1.4 ± 0.21 1.0 ± 0.04 1.0 ± 0.03 0.06 
22:6n-3 12.2 ± 0.32 13.3 ± 13.28 13.4 ± 0.28 13.9 ± 0.37 0.06 
Ʃ n-3
4 26.0 ± 0.44
c 28.4 ± 0.55b 28.4 ± 0.34b 30.6 ± 0.77a 0.003 
n-6/n-3 0.23 ± 0.00
a 0.18 ± 0.01b 0.21 ± 0.00a 0.18 ± 0.01b 0.001 
EPA+DHA 21.4 ± 0.37
b 24.0 ± 0.40a 21.8 ± 0.22b 21.8 ± 0.44b 0.003 
1Includes 15:0, 17:0, and 24:0. 
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Table 9. Lipid content (% of wet weight) and fatty acid composition (% of total) in 
erythrocytes of Atlantic salmon fed the experimental diets for 70 days at low (12°C) water 
temperature. Data are shown as mean values using tank as a statistical unit (n = 3, being each 
sample represented by a pool of five fish) with their standard errors. Different superscript 
letters indicate statistically significant differences (p < 0.05). 
 
     LOW FO HIGH FO LOW DHA-CA HIGH DHA-CA ANOVA p-value 
Total fat 2.6 ± 0.13 2.6 ± 0.03 2.4 ± 0.05 2.6 ± 0.26 0.74 
14:0 1.3 ± 0.05b 1.6 ± 0.09a 1.3 ± 0.03b 1.3 ± 0.03b 0.01 
16:0   15.1 ± 0.16ab 15.3 ± 0.10a 14.5 ± 0.46ab 14.2 ± 0.22b 0.08 
18:0 2.6 ± 0.09 2.4 ± 0.08 2.6 ± 0.07 2.6 ± 0.09 0.25 
Ʃ SFA
1 20.2 ± 0.12ab 20.6 ± 0.29a 19.6 ± 0.29b 19.5 ± 0.06b 0.02 
16:1n-7 1.5 ± 0.03a 1.5 ± 0.08a 1.2 ± 0.04b 1.2 ± 0.05b 0.005 
18:1n-11 1.3 ± 0.07b 1.5 ± 0.01a 1.2 ± 0.02b 1.3 ± 0.01b 0.005 
18:1n-9 18.1 ± 0.36a 14.5 ± 0.73c 17.6 ± 0.33ab 15.5 ± 1.07bc 0.02 
18:1n-7 1.9 ± 0.01b 1.9 ± 0.05b 2.0 ± 0.05ab 2.1 ± 0.08a 0.05 
20:1n-9    4.2 ± 0.06ab 4.3 ± 0.12a 3.8 ± 0.15bc 3.6 ± 0.15c 0.02 
22:1n-11 3.5 ± 0.17a 3.7 ± 0.12a 3.0 ± 0.10b 3.0 ± 0.12b 0.008 
Ʃ MUFA
2 33.9 ± 0.61 30.9 ± 1.16 32.7 ± 0.10 30.9 ± 1.12 0.11 
18:2n-6 3.0 ± 0.11a 2.4 ± 0.02c 3.2 ± 0.05a 2.7 ± 0.08b 0.0003 
20:4n-6 0.9 ± 0.05 0.9 ± 0.10 0.9 ± 0.11 0.8 ± 0.09 0.85 
Ʃ n-6
3 6.4 ± 0.05 5.6 ± 0.25 6.7 ± 0.56 6.1 ± 0.33 0.21 
18:3n-3 1.3 ± 0.05c 1.1 ± 0.01c 2.4 ± 0.11b 3.3 ± 0.15a < .0001 
18:4n-3 0.2 ± 0.09 nd 0.2 ± 0.12 nd  
20:3n-3 0.2 ± 0.02bc 0.2 ± 0.09c 0.5 ± 0.06ab 0.7 ± 0.06a 0.0009 
20:4n-3 0.7 ± 0.07 0.7 ± 0.01 0.6 ± 0.06 0.4 ± 0.21 0.3 
20:5n-3 6.1 ± 0.10b 6.8 ± 0.29a 5.2 ± 0.08c 5.2 ± 0.10c 0.0003 
22:5n-3 1.6 ± 0.15 1.7 ± 0.06 1.4 ± 0.24 1.1 ± 0.52 0.56 
22:6n-3 27.3 ± 0.54 30.1 ± 0.66 28.3 ± 1.11 30.1 ± 0.62 0.08 
Ʃ n-3
4 37.4 ± 0.66 40.6 ± 1.04 38.6 ± 0.88 40.8 ± 0.90 0.07 
n-6/n-3 0.17 ± 0.00 0.14 ± 0.00 0.17 ± 0.02 0.15 ± 0.01 0.1 
Omega-3 index
4
 33.4 ± 0.6
b 37.1 ± 0.9a 33.7 ± 1.1b 35.6 ± 0.6ab 0.05 
      
nd, not determined 
1Includes 15:0, 17:0, 20:0, 22:0, and 24:0. 
2Includes 14:1n-5, 16:1n-5, 16:1n-9, 17:1n-7, 20:1n-11, 20:1n-7, 22:1n-7, and 24:1n-9. 
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Table 10. Lipid content (% of wet weight), fatty acid composition (% of total), and sterols 
(mg kg
-1
) in the liver of Atlantic salmon fed the experimental diets for 70 days at low (12°C) 
water temperature. Data are shown as mean values using tank as a statistical unit (n = 3, being 
each sample represented by a pool of five fish) with their standard errors. Different 
superscript letters indicate statistically significant differences (p<0.05). 
 
  LOW FO HIGH FO LOW DHA-CA HIGH DHA-CA ANOVA p-value 
Total fat 6.3 ± 0.66 6.4 ± 0.25 6.3 ± 0.23 5.8 ± 0.27 0.65 
14:0 1.6 ± 0.07ab 1.8 ± 0.12a 1.4 ± 0.03b 1.4 ± 0.04b 0.02 
16:0   18.8 ± 0.54 18.5 ± 0.17 18.5 ± 0.23 18.3 ± 0.21 0.76 
18:0 4.4 ± 0.20 4.4 ± 0.16 4.5 ± 0.07 4.7 ± 0.13 0.39 
Ʃ SFA
1 25.6 ± 0.87 25.6 ± 0.28 25.5 ± 0.32 25.7 ± 0.27 0.99 
16:1n-7 1.8 ± 0.10a 1.5 ± 0.10ab 1.4 ± 0.07b 1.3 ± 0.06b 0.02 
16:1n-9 0.4 ± 0.04 0.4 ± 0.00 0.4 ± 0.02 0.4 ± 0.01 0.93 
18:1n-9 23.3 ± 0.59a 19.1 ± 0.47c 21.7 ± 0.29ab 20.3 ± 0.59bc 0.002 
20:1n-7 3.3 ± 0.07b 3.7 ± 0.07a 3.2 ± 0.12bc 3.0 ± 0.10c 0.004 
22:1n-11 0.5 ± 0.08c 0.6 ± 0.03bc 0.8 ± 0.13ab 1.0 ± 0.03a 0.01 
Ʃ MUFA
2 30.3 ± 0.87a 26.7 ± 0.35b 28.4 ± 0.29b 26.9 ± 0.65b 0.008 
18:2n-6 3.0 ± 0.04a 2.3 ± 0.07b 3.0 ± 0.07a 2.6 ± 0.16b 0.003 
20:2n-6 0.7 ± 0.05 0.6 ± 0.04 0.8 ± 0.06 0.7 ± 0.01 0.06 
20:3n-6 1.1 ± 0.06a 0.8 ± 0.07b 1.1 ± 0.11a 1.0 ± 0.03ab 0.03 
20:4n-6 1.5 ± 0.09 1.8 ± 0.09 1.7 ± 0.13 1.5 ± 0.05 0.13 
Ʃ n-6
3 6.3 ± 0.12a 5.5 ± 0.14b 6.6 ± 0.11a 5.8 ± 0.16b 0.002 
18:3n-3 1.0 ± 0.06c 0.8 ± 0.04c 1.7 ± 0.08b 2.4 ± 0.18a < .0001 
20:3n-3 0.00 ± 0b 0.2 ± 0.16ab 0.3 ± 0.07a 0.5 ± 0.05a 0.03 
20:5n-3 5.1 ± 0.06a 5.5 ± 0.14a 4.7 ± 0.14b 4.6 ± 0.07b 0.002 
22:5n-3 1.8 ± 0.13 1.7 ± 0.21 1.8 ± 0.16 1.7 ± 0.03 0.95 
22:6n-3 28.1 ± 0.86b 32.5 ± 0.55a 30.0 ± 0.84ab 31.3 ± 1.11a 0.03 
Ʃ n-3









n-6/n-3 0.17 ± 0.00
a 0.14 ± 0.00b 0.17 ± 0.00a 0.14 ± 0.01b 0.0003 
EPA+DHA 33.2 ± 0.90
b 38.0 ± 0.47a 34.7 ± 0.70b 35.9 ± 0.15ab 0.02 
      
Sterols      
   Cholesterol 3780 ± 425 3894 ± 241 3840 ± 262 3715 ± 437 0.69 
   Ʃ Phytosterols 52.1 ± 7.9a 51.8 ± 15.2a 67.8 ± 13.4b 58.2 ± 10.6ab 0.03 
   β-Sitosterol 15.6 ± 5.4 16.7 ± 9.2 16.6 ± 7.5 14.4 ± 5.2 0.90 
   Campesterol 16.2 ± 5.1a 12.1 ± 5.5a 26.1 ± 9.2b 21.7 ± 5.8b 0.0005 
   Brassicasterol 5.2 ± 2.8 5.9 ± 1.9 7.7 ± 2.0 5.9 ± 1.7 0.39 
   Sitostanol 2.5 ± 0.8a 2.6 ± 1.3ab 3.4 ± 1.0b 3.3 ± 0.6b 0.04 
1Includes 15:0, 17:0, 20:0, 22:0, and 24:0. 
2Includes 14:1n-5, 16:1n-5, 17:1n-7, 18:1n-7, 20:1n-11, 20:1n-9, and 22:1n-9. 
3Includes 18:3n-6. 
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Table 11. Selected differentially expressed genes (DEG) in the liver from Atlantic salmon fed 
diets containing fish oil (FO) or oil from the n-3 rich modified canola (DHA-CA) for 70 days 
at low (12°C) water temperature. Data are presented as relative to the diet containing high 
levels of FO, which is regarded as reference level. Significantly up-regulated genes (log2-
expression ratio > |0.6| (1.5-fold), p < 0.05) are highlighted with red scale.  
 
  LOW FO LOW DHA-CA HIGH DHA-CA 
Total DEG    
     Up-regulated  85 79 13 
     Down-regulated  96 66 4 
Diphosphomevalonate decarboxylase 1.88 2.05 1.29 
Endothelial lipase   3.14 2.44 1.45 
Farnesyl diphosphate synthase 1  2.94 3.32 1.68 
Farnesyl diphosphate synthase 2  2.94 3.27 1.65 
Fatty acid-binding protein. brain 2.50 1.88 1.15 
Hydroxymethylglutaryl-CoA synthase  2.40 2.80 1.52 
Insulin-induced gene 1   1.82 2.01 1.68 
Isopentenyl-diphosphate Delta-isomerase 1   2.52 2.50 1.36 
7-Dehydrocholesterol reductase 1.65 1.44 1.41 
7-Dehydrocholesterol reductase 1.79 1.91 1.61 
Lanosterol 14-alpha demethylase 1  2.04 1.54 1.22 
Lanosterol 14-alpha demethylase  2 1.53 1.81 1.26 
Lanosterol synthase  2.14 1.90 1.47 
Lipin 1   1.80 1.58 1.63 
Mevalonate kinase 1.50 1.94 1.22 
Squalene monooxygenase 1 1.34 1.73 1.30 
Squalene monooxygenase 2 2.26 2.42 1.61 
Squalene synthase   1.90 2.00 1.40 
Stearoyl-CoA desaturase b   3.10 2.73 2.69 
Sterol-4-alpha-carboxylate 3-dehydrogenase 1 1.77 1.58 1.26 
Sterol-4-alpha-carboxylate 3-dehydrogenase 2  1.44 1.69 1.39 
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